test

Michael Elgort

@Parkman Healthcare Partners Llc

Latest period2024 - Q3ReportedManaged Assets$783.443MTotal holdings93
Assets growth rate4.94%Assets growth rate (2-Q avg)-1.72%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Parkman Healthcare Partners Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 93 positions.

Assets under management

The assets under management (AUM) of Parkman Healthcare Partners Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 783.443M in assets, with a quarterly growth rate of 4.94% and a 2-quarter average growth rate of -1.72%. The portfolio is managed by Michael Elgort, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ABTAbbott Labs
Recent Activity
Increased 1.39%
1.8%
$14.092M
123,601 shares@ $114.01 avg price
DAWNDay One Biopharmaceuticals I
Recent Activity
Increased 1.69%
1.65%
$12.873M
924,140 shares@ $13.93 avg price
GILDGilead Sciences Inc
Recent Activity
Increased 3.22%
1.39%
$10.817M
129,025 shares@ $83.84 avg price
SLNSilence Therapeutics Plc
Recent Activity
Increased 71.78%
1.16%
$9.051M
497,870 shares@ $18.19 avg price
CSTLCastle Biosciences Inc
Recent Activity
Increased 6.55%
1.08%
$8.444M
296,071 shares@ $28.53 avg price
REPLReplimune Group Inc
Recent Activity
Increased 45.48%
1.07%
$8.371M
763,747 shares@ $10.96 avg price
CDMOAvid Bioservices Inc
Recent Activity
Increased 15.92%
1.05%
$8.193M
719,965 shares@ $11.39 avg price
FOLDAmicus Therapeutics Inc
Recent Activity
Increased 20.48%
0.83%
$6.465M
605,318 shares@ $10.68 avg price
RAREUltragenyx Pharmaceutical In
Recent Activity
Increased 9.47%
0.78%
$6.081M
109,468 shares@ $55.55 avg price
CVRXCvrx Inc
Recent Activity
Increased 52.57%
0.77%
$6.016M
682,897 shares@ $8.82 avg price